Update ISIN in trading and settlement systems to DK0060615755 to ensure accurate processing of transactions. No investment thesis implications.
ASND drugs
ASND drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 21 $240.29entry
- T+1 · 7mo ago −3.85%α −4.86% · $231.05
- T+5 · 7mo ago −7.58%α −8.66% · $222.08
- T+20 · 6mo ago −1.10%α −6.02% · $237.64
- T+60 · 4mo ago +8.12%α +1.22% · $259.80
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ascendis Pharma A/S updated the International Securities Identification Number (ISIN) for its ordinary shares to DK0060615755 following its direct listing on Nasdaq, replacing the previously disclosed ISIN DK0060606333. The CUSIP number and ticker symbol (ASND) remain unchanged.
Key Facts
- Updated ISIN for ordinary shares to DK0060615755 as confirmed by Denmark's National Numbering Agency
- Previous ISIN DK0060606333 is no longer valid
- CUSIP number (K08588103) and ticker symbol (ASND) remain unchanged
- Update relates to administrative details following direct listing on Nasdaq
Financial Impact
No financial impact
Risk Factors
- Potential for trade fails or settlement issues if outdated ISIN is used
- Temporary confusion among investors or systems not updated with new ISIN
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-165330 |
| Document: 0001193125-26-165330-index-headers.html | 0001193125-26-165330 |
| Document: 0001193125-26-165330-index.html | 0001193125-26-165330 |
| Document: 0001193125-26-165330.txt | 0001193125-26-165330 |
Track record
41 reports on ASND
14 of 19 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 25 of 27 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $271.73 −0.08% settles Feb 12
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $275.39 Now $271.73 −1.33% settles Feb 11
- Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
- Nov 6, 202610d ago 6-K Bullish 6/10 Entry $259.85 Now $271.73 +4.57% settles Feb 5
- Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $271.73 +5.81% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $253.45 Now $271.73 +7.21% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $271.73 +8.62% settles Feb 1
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $271.73 +10.53% settles Jan 25
- Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $271.73 +20.63% settles Jan 13
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers